Program overview
Context
Indication: Adenocarcinoma of the Pancreas
Mechanism: Unknown
Modality: Unknown
Sponsor: University of Michigan Rogel Cancer Center
MK-1775 is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Adenocarcinoma of the Pancreas
Mechanism: Unknown
Modality: Unknown
Sponsor: University of Michigan Rogel Cancer Center
Registry: 0/5
Timeline: 1/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 0/5
https://clinicaltrials.gov/study/NCT02037230
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02037230 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |